A detailed history of Jacobson & Schmitt Advisors, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Jacobson & Schmitt Advisors, LLC holds 2,747 shares of ABT stock, worth $308,817. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,747
Previous 2,774 0.97%
Holding current value
$308,817
Previous $288,000 8.68%
% of portfolio
0.06%
Previous 0.07%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$100.07 - $118.13 $2,701 - $3,189
-27 Reduced 0.97%
2,747 $313,000
Q2 2024

Aug 12, 2024

BUY
$100.73 - $112.44 $279,425 - $311,908
2,774 New
2,774 $288,000
Q2 2022

Aug 08, 2022

SELL
$102.07 - $123.37 $183,726 - $222,066
-1,800 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$115.53 - $141.46 $207,954 - $254,628
1,800 New
1,800 $253,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Jacobson & Schmitt Advisors, LLC Portfolio

Follow Jacobson & Schmitt Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobson & Schmitt Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobson & Schmitt Advisors, LLC with notifications on news.